Pharma channel feed

Two for two: GSK fol­lows Pfiz­er, se­cures ad­comm thumbs-up for RSV vac­cine in old­er adults

3 years ago
FDA+

Io­n­is in­tro­duces young 'ris­ing star' sci­en­tists, shar­ing re­search projects and pas­sions on new pod­cast

3 years ago
Marketing

CBER di­rec­tor Pe­ter Marks says FDA is grow­ing to keep up with cell and gene ther­a­pies

3 years ago
FDA+

Fol­low­ing the gov­ern­men­t's lead, Lil­ly caps out-of-pock­et costs for in­sulin at $35 per month

3 years ago

FDA re­jects Cy­to­ki­net­ic­s' heart fail­ure drug, but the biotech has a back­up

3 years ago
FDA+

Strug­gling No­vavax de­tails a wave of red ink and plots sur­vival course af­ter rais­ing 'go­ing con­cern' alert

3 years ago

No­vavax rais­es warn­ing about abil­i­ty to stay in busi­ness

3 years ago

Pfiz­er's RSV vac­cine for old­er adults nabs FDA ad­comm rec­om­men­da­tion

3 years ago
FDA+

Phar­mas' rep­u­ta­tions mat­ter, es­pe­cial­ly when it comes to writ­ing pre­scrip­tions, new sur­vey finds

3 years ago
Marketing

FDA set to open com­ments on AI use in phar­ma man­u­fac­tur­ing

3 years ago
AI
Manufacturing

Pfiz­er was warned of Ly­me study prob­lems months ago, tri­al re­search star­tup's CEO tells em­ploy­ees

3 years ago
R&D
Outsourcing

Rare Dis­ease Day pulls more par­tic­i­pa­tion, cre­ativ­i­ty and di­ver­si­ty in 2023 phar­ma and ad­vo­ca­cy cam­paigns

3 years ago
Marketing

Mar­ket­ingRx roundup: Ab­b­Vie joins Tik­Tok with friend­ly ex­pert chats; Pfiz­er shops $2.8B mar­ket­ing ac­count

3 years ago
Marketing

Mer­ck’s Keytru­da fails more prostate and lung can­cer PhI­II tri­als

3 years ago
R&D

Boehringer In­gel­heim taps fash­ion stu­dents in lat­est 'Un­wear­able' ef­fort to spot­light rare pso­ri­a­sis con­di­tion

3 years ago
Marketing

As­traZeneca ex­pands Cana­da R&D work, to add 500 jobs

3 years ago
R&D

Jazz los­es ap­peal, will have patent delist­ed from the Or­ange Book

3 years ago
Law

Gay men's health group and ad agency part­ner say FDA blood do­na­tion pro­pos­al 'still falls short'

3 years ago
Marketing

FDA neu­ro­science chief Bil­ly Dunn, who led Aduhelm ap­proval, will leave agency

3 years ago
FDA+

Dr. Red­dy's to buy Mayne Phar­ma’s US gener­ics drug list for at least $90M

3 years ago
Deals

Pfiz­er makes moves to ac­quire Seagen in po­ten­tial $30B+ deal

3 years ago
Deals

Eu­ro­pean reg­u­la­tors rec­om­mend re­jec­tion of Mer­ck’s Covid-19 drug mol­nupi­ravir

3 years ago
Coronavirus

Pfiz­er's Paxlovid gets March FDA ad­vi­so­ry meet­ing to dis­cuss full ap­proval

3 years ago
Coronavirus

GSK's bell­wether Zan­tac court date pushed to Ju­ly

3 years ago
Law
First page Previous page 142143144145146147148 Next page Last page
A service from the Financial Times